A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementiaShifu Xiao, Raoli He, Weihong Kuang et al.|Alzheimer s Research & Therapy|2021Cited by 200
Efficacy and safety of cinepazide maleate injection in patients with acute ischemic stroke: a multicenter, randomized, double-blind, placebo-controlled trialJun Ni, Baojun Wang, Tianming Lu et al.|BMC Neurology|2020Cited by 18